|
Vol 42(2008) N 3 p. 442-448; A.E. Berezhnoy1, A.A. Wainson2, N.N. Kasatkina2, O.A. Khokhlova1, A.S. Ostrovskaya1, E.V. Volodina1, A.Yu. Baryshnikov2, G.P. Georgiev1, S.S. Larin1 High-dose γ-irradiation enhances the expression of a transgene controlled by the immediate-early CMV promoter in stably transfected tumor cells 1Institute of Gene Biology, Russian Academy of Sciences, Moscow, 119334, Russia2Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, 115478, Russia Received - 2007-10-02; Accepted - 2007-12-19 γ-irradiation is commonly used to inactivate whole-cell anticancer vaccines containing viable tumor cells. To evaluate the effect of γ-irradiation on transgene expression in tumor cells, human and mouse cell lines were stably transfected with constructs expressing the granulocyte macrophage colony-stimulating factor (GM-CSF) or green fluorescent protein (GFP) gene under the control of the immediate-early CMV promoter. Irradiation of cells at 20-100 Gy caused a loss of proliferation capacity and gradual cell death, with the survival depending on the irradiation dose. G2/M cells accumulated in irradiated cultures, while the portion of S-phase cells was reduced. Surviving cells displayed activation of β-galactosidase and morphological changes associated with cell senescence. Mitochondrial dehydrogenase activity did not change with the irradiation dose. Irradiated cells retained transgene expression. Moreover, the amount of secreted GM-CSF and GFP production significantly increased after γ-irradiation, up to tenfold in cells exposed to 100 Gy. Transgene expression increased gradually and positively correlated with the total irradiation dose. The results demonstrate that γ-irradiation at 100 Gy is optimal for whole-cell anticancer vaccine inactivation. transgenic tumor cells, γ-irradiation, anticancer vaccines |